Skip to main content
SpringerLink
Log in

S3-Leitline Bewegungstherapie bei onkologischen Erkrankungen nimmt erste Hürde

S3 guideline exercise therapy for oncological diseases clears the first hurdle

  • Onkologische Leitlinie - kurzgefasst
  • Published:
Forum Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Christensen JF, Simonsen C, Hojman P (2018) Exercise training in cancer control and treatment. Compr Physiol 9(1):165–205

    Article  Google Scholar 

  2. Sweegers MG et al (2018) Which exercise prescriptions improve quality of life and physical function in patients with cancer during and following treatment? A systematic review and meta-analysis of randomised controlled trials. Br J Sports Med 52(8):505–513

    Article  Google Scholar 

  3. Scott JM et al (2018) Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis. J Clin Oncol 36(22):2297–2305

    Article  CAS  Google Scholar 

  4. Jones LW et al (2016) Exercise and risk of cardiovascular events in women with nonmetastatic breast cancer. J Clin Oncol 34(23):2743–2749

    Article  CAS  Google Scholar 

  5. Scott JM et al (2018) Exercise therapy and cardiovascular toxicity in cancer. Circulation 137(11):1176–1191

    Article  Google Scholar 

  6. Duregon F et al (2018) Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: a systematic review. Crit Rev Oncol 121:90–100

    Article  Google Scholar 

  7. Zimmer P et al (2016) Effects of exercise interventions and physical activity behavior on cancer related cognitive impairments: a systematic review. Biomed Res Int p:1820954

    Google Scholar 

  8. Campbell KL, Neil SE, Winters-Stone KM (2012) Review of exercise studies in breast cancer survivors: attention to principles of exercise training. Br J Sports Med 46(13):909–916

    Article  Google Scholar 

  9. Winters-Stone KM et al (2014) Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema. J Cancer Surviv 8(2):260–268

    Article  Google Scholar 

  10. Cormie P et al (2017) The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects. Epidemiol Rev 39(1):71–92

    Article  Google Scholar 

  11. Ashcraft KA et al (2019) Exercise as adjunct therapy in cancer. Semin Radiat Oncol 29(1):16–24

    Article  Google Scholar 

  12. Cormie P et al (2018) Clinical oncology society of Australia position statement on exercise in cancer care. Med J Aust 209(4):184–187

    Article  Google Scholar 

  13. Campbell KL, Winters-Stone KM, Wiskemann J et al (2019) Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc 51(11):2375–2390

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. AG Onkologische Sport- und Bewegungstherapie, Abteilung Medizinische Onkologie, Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Deutschland

    Joachim Wiskemann FECSS, FACSM

  2. AG Onkologische Bewegungsmedizin, Klinik I für Innere Medizin, Centrum für Integrierte Onkologie Aachen Bonn Köln Düsseldorf, Uniklinik Köln, Köln, Deutschland

    Freerk Baumann

Authors
  1. Joachim Wiskemann FECSS, FACSM
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Freerk Baumann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joachim Wiskemann FECSS, FACSM.

Ethics declarations

Interessenkonflikt

J. Wiskemann und F. Baumann geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wiskemann, J., Baumann, F. S3-Leitline Bewegungstherapie bei onkologischen Erkrankungen nimmt erste Hürde. Forum 35, 379–380 (2020). https://doi.org/10.1007/s12312-020-00849-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12312-020-00849-1

Search

Navigation